Amicus Therapeutics (FOLD) reported fourth-quarter 2024 adjusted earnings of 9 cents per share, which missed the Zacks Consensus Estimate of 10 cents. The company had reported earnings of 1 cent per share in the year-ago quarter.See the Zacks Earnings Calendar to stay ahead of market-making news.Revenues in the fourth quarter totaled $149.7 million, up 30% year over year on a reported basis and a constant-currency (cc) basis. The figure marginally beat the Zacks Consensus Estimate of $149 million. The top l ...